Comparative performance of human papillomavirus messenger RNA versus DNA screening tests at baseline and 48 months in the HPV FOCAL trial

Author:

Cook Darrel A.ORCID,Smith Laurie W.,Law Jennifer H.,Mei Wendy,Gondara Lovedeep,van Niekerk Dirk J.,Ceballos Kathy M.,Jang Dan,Chernesky Max,Franco Eduardo L.,Ogilvie Gina S.,Coldman Andrew J.,Krajden Mel

Funder

Canadian Institutes of Health Research

Hologic Inc., SanDiego, CA, USA

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference25 articles.

1. Changes to the National Cervical Screening Program;Radar,2015

2. Newsletter Dutch Population Screening for Cervical Cancer;Rijkinstituut voor Voksgezondheid en Milieu,2017

3. Deciding How Best to Roll out HPV Testing as the Primary Cervical Screening Test;Public Health England,2017

4. A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial);Ogilvie;BMC Cancer,2010

5. HPV for cervical cancer screening (HPV FOCAL): complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer;Ogilvie;Int. J. Cancer,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3